TY - JOUR
T1 - Transfectant influenza A viruses are effective recombinant immunogens in the treatment of experimental cancer
AU - Restifo, Nicholas P.
AU - Surman, Deborah R.
AU - Zheng, Hongyong
AU - Palese, Peter
AU - Rosenberg, Steven A.
AU - García-Sastre, Adolfo
N1 - Funding Information:
We thank Scott Kerns and Paul Spiess for excellent technical assistance, Martha Blalock for her graphical talents, and Kari Irvine and Willem Overwijk for helpful advice and discussions. We are also grateful to Dr. Nancy J. Cox for the influenza A/Beijing/32/92 Virus. This work was supported, in part, by grants from the National Institutes of Health to P.P. and A.G.-S.
PY - 1998/9/15
Y1 - 1998/9/15
N2 - Using reverse genetics methods, we constructed three different transfectant influenza A viruses encoding an L(d)-restricted, nine amino- acid-long fragment, corresponding to amino-acid residues 876-884, of β- galactosidase (β-gal). Sequences encoding this epitope were nested within the hemagglutinin (HA) or neuraminidase (NA) open reading frames. Alternatively, an independent β-gal mini-gene, preceded by an endoplasmic reticulum insertion signal sequence, was placed in a bicistronic arrangement in the NA RNA segment of the virus. All three transfectants mediated the presentation of the epitope to a β-gal-specific CTL clone. Furthermore, each of the three transfectant viruses expressing the β-gal fragment elicited specific cytolytic responses in vivo. Most importantly, these H1N1 transfectants mediated the regression of established murine pulmonary metastases. Tumor regression in mice was also achieved in the presence of preexisting immunity against an H3N2 influenza A virus serotype. Nononcogenic and nonintegrating, transfectant influenza A viruses are attractive candidates for development as antitumor vaccines.
AB - Using reverse genetics methods, we constructed three different transfectant influenza A viruses encoding an L(d)-restricted, nine amino- acid-long fragment, corresponding to amino-acid residues 876-884, of β- galactosidase (β-gal). Sequences encoding this epitope were nested within the hemagglutinin (HA) or neuraminidase (NA) open reading frames. Alternatively, an independent β-gal mini-gene, preceded by an endoplasmic reticulum insertion signal sequence, was placed in a bicistronic arrangement in the NA RNA segment of the virus. All three transfectants mediated the presentation of the epitope to a β-gal-specific CTL clone. Furthermore, each of the three transfectant viruses expressing the β-gal fragment elicited specific cytolytic responses in vivo. Most importantly, these H1N1 transfectants mediated the regression of established murine pulmonary metastases. Tumor regression in mice was also achieved in the presence of preexisting immunity against an H3N2 influenza A virus serotype. Nononcogenic and nonintegrating, transfectant influenza A viruses are attractive candidates for development as antitumor vaccines.
UR - http://www.scopus.com/inward/record.url?scp=0032530630&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032530630&partnerID=8YFLogxK
U2 - 10.1006/viro.1998.9330
DO - 10.1006/viro.1998.9330
M3 - Article
C2 - 9740780
AN - SCOPUS:0032530630
SN - 0042-6822
VL - 249
SP - 89
EP - 97
JO - Virology
JF - Virology
IS - 1
ER -